205 related articles for article (PubMed ID: 17261781)
1. Implications for estrogens in Parkinson's disease: an epidemiological approach.
Ragonese P; D'Amelio M; Savettieri G
Ann N Y Acad Sci; 2006 Nov; 1089():373-82. PubMed ID: 17261781
[TBL] [Abstract][Full Text] [Related]
2. Estrogen and SERM neuroprotection in animal models of Parkinson's disease.
Morissette M; Al Sweidi S; Callier S; Di Paolo T
Mol Cell Endocrinol; 2008 Aug; 290(1-2):60-9. PubMed ID: 18515001
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in neurotoxicity of the nigrostriatal dopaminergic system: implications for Parkinson's disease.
Dluzen DE; McDermott JL
J Gend Specif Med; 2000; 3(6):36-42. PubMed ID: 11253381
[TBL] [Abstract][Full Text] [Related]
4. Neuroprotective actions of sex steroids in Parkinson's disease.
Bourque M; Dluzen DE; Di Paolo T
Front Neuroendocrinol; 2009 Jul; 30(2):142-57. PubMed ID: 19410597
[TBL] [Abstract][Full Text] [Related]
5. Paraquat and Parkinson's disease.
Berry C; La Vecchia C; Nicotera P
Cell Death Differ; 2010 Jul; 17(7):1115-25. PubMed ID: 20094060
[TBL] [Abstract][Full Text] [Related]
6. Sex dimorphisms in the neuroprotective effects of estrogen in an animal model of Parkinson's disease.
Gillies GE; Murray HE; Dexter D; McArthur S
Pharmacol Biochem Behav; 2004 Jul; 78(3):513-22. PubMed ID: 15251260
[TBL] [Abstract][Full Text] [Related]
7. Reproductive factors and Parkinson's disease: a multicenter case-control study.
Nicoletti A; Nicoletti G; Arabia G; Annesi G; De Mari M; Lamberti P; Grasso L; Marconi R; Epifanio A; Morgante L; Cozzolino A; Barone P; Quattrone A; Zappia M
Mov Disord; 2011 Dec; 26(14):2563-6. PubMed ID: 21956541
[TBL] [Abstract][Full Text] [Related]
8. Age at menopause predicts age at onset of Parkinson's disease.
Ragonese P; D'Amelio M; Callari G; Salemi G; Morgante L; Savettieri G
Mov Disord; 2006 Dec; 21(12):2211-4. PubMed ID: 17029261
[TBL] [Abstract][Full Text] [Related]
9. Loss of aromatase cytochrome P450 function as a risk factor for Parkinson's disease?
Morale MC; L'Episcopo F; Tirolo C; Giaquinta G; Caniglia S; Testa N; Arcieri P; Serra PA; Lupo G; Alberghina M; Harada N; Honda S; Panzica GC; Marchetti B
Brain Res Rev; 2008 Mar; 57(2):431-43. PubMed ID: 18063054
[TBL] [Abstract][Full Text] [Related]
10. Parkinson's disease and reproductive life events.
Martignoni E; Nappi RE; Citterio A; Calandrella D; Corengia E; Fignon A; Zangaglia R; Riboldazzi G; Pacchetti C; Nappi G
Neurol Sci; 2002 Sep; 23 Suppl 2():S85-6. PubMed ID: 12548356
[TBL] [Abstract][Full Text] [Related]
11. Gender disparities in Parkinson's disease.
Shulman LM; Bhat V
Expert Rev Neurother; 2006 Mar; 6(3):407-16. PubMed ID: 16533144
[TBL] [Abstract][Full Text] [Related]
12. A case control study of women with Parkinson's disease and their fertility characteristics.
Yadav R; Shukla G; Goyal V; Singh S; Behari M
J Neurol Sci; 2012 Aug; 319(1-2):135-8. PubMed ID: 22647587
[TBL] [Abstract][Full Text] [Related]
13. Reproductive factors and clinical features of Parkinson's disease.
Cereda E; Barichella M; Cassani E; Caccialanza R; Pezzoli G
Parkinsonism Relat Disord; 2013 Dec; 19(12):1094-9. PubMed ID: 23931933
[TBL] [Abstract][Full Text] [Related]
14. Glatiramer acetate could be a potential therapeutic agent for Parkinson's disease through its neuroprotective and anti-inflammatory effects.
Tsai SJ
Med Hypotheses; 2007; 69(6):1219-21. PubMed ID: 17548170
[TBL] [Abstract][Full Text] [Related]
15. Risk is in the air: an intranasal MPTP (1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine) rat model of Parkinson's disease.
Prediger RD; Rial D; Medeiros R; Figueiredo CP; Doty RL; Takahashi RN
Ann N Y Acad Sci; 2009 Jul; 1170():629-36. PubMed ID: 19686204
[TBL] [Abstract][Full Text] [Related]
16. Epidemiologic studies of environmental exposures in Parkinson's disease.
Elbaz A; Tranchant C
J Neurol Sci; 2007 Nov; 262(1-2):37-44. PubMed ID: 17673256
[TBL] [Abstract][Full Text] [Related]
17. Estrogen and movement disorders.
Kompoliti K
Clin Neuropharmacol; 1999; 22(6):318-26. PubMed ID: 10626091
[TBL] [Abstract][Full Text] [Related]
18. Parkinson's disease and cancer: insights for pathogenesis from epidemiology .
D'Amelio M; Ragonese P; Sconzo G; Aridon P; Savettieri G
Ann N Y Acad Sci; 2009 Feb; 1155():324-34. PubMed ID: 19250224
[TBL] [Abstract][Full Text] [Related]
19. New onset heightened interest or drive for gambling, shopping, eating or sexual activity in patients with Parkinson's disease: the role of dopamine agonist treatment and age at motor symptoms onset.
Giladi N; Weitzman N; Schreiber S; Shabtai H; Peretz C
J Psychopharmacol; 2007 Jul; 21(5):501-6. PubMed ID: 17446202
[TBL] [Abstract][Full Text] [Related]
20. Oestrogen and nigrostriatal dopaminergic neurodegeneration: animal models and clinical reports of Parkinson's disease.
Liu B; Dluzen DE
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):555-65. PubMed ID: 17581209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
